14-day Premium Trial Subscription Try For FreeTry Free
$0.0350
+0 (+0%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0300 $0.0600 Thursday, 2nd May 2024 NAVB stock ended at $0.0350. During the day the stock fluctuated 28.57% from a day low at $0.0350 to a day high of $0.0450.
90 days $0.0300 $0.0600
52 weeks $0.0210 $0.192

Historical Navidea Biopharmaceuticals Inc prices

Date Open High Low Close Volume
May 02, 2024 $0.0350 $0.0450 $0.0350 $0.0350 19 249
May 01, 2024 $0.0483 $0.0483 $0.0350 $0.0350 3 736
Apr 30, 2024 $0.0350 $0.0455 $0.0300 $0.0360 9 441
Apr 29, 2024 $0.0420 $0.0600 $0.0330 $0.0350 227 928
Apr 26, 2024 $0.0400 $0.0400 $0.0381 $0.0381 2 796
Apr 25, 2024 $0.0375 $0.0440 $0.0375 $0.0376 15 041
Apr 24, 2024 $0.0368 $0.0375 $0.0368 $0.0375 2 138
Apr 23, 2024 $0.0405 $0.0439 $0.0368 $0.0368 6 635
Apr 22, 2024 $0.0480 $0.0500 $0.0365 $0.0440 55 172
Apr 19, 2024 $0.0350 $0.0450 $0.0341 $0.0350 337 616
Apr 18, 2024 $0.0360 $0.0375 $0.0350 $0.0350 15 445
Apr 17, 2024 $0.0360 $0.0479 $0.0360 $0.0420 12 191
Apr 16, 2024 $0.0400 $0.0400 $0.0341 $0.0342 23 476
Apr 15, 2024 $0.0400 $0.0600 $0.0400 $0.0400 16 750
Apr 12, 2024 $0.0405 $0.0480 $0.0330 $0.0400 96 638
Apr 11, 2024 $0.0380 $0.0430 $0.0380 $0.0381 2 254
Apr 10, 2024 $0.0410 $0.0410 $0.0380 $0.0380 34 573
Apr 09, 2024 $0.0330 $0.0480 $0.0330 $0.0412 40 646
Apr 08, 2024 $0.0340 $0.0490 $0.0340 $0.0480 6 760
Apr 05, 2024 $0.0340 $0.0500 $0.0340 $0.0395 218 752
Apr 04, 2024 $0.0332 $0.0500 $0.0330 $0.0500 56 252
Apr 03, 2024 $0.0330 $0.0360 $0.0330 $0.0359 131 877
Apr 02, 2024 $0.0330 $0.0380 $0.0330 $0.0373 131 602
Apr 01, 2024 $0.0330 $0.0400 $0.0330 $0.0330 119 106
Mar 28, 2024 $0.0330 $0.0413 $0.0330 $0.0365 64 218
Click to get the best stock tips daily for free!

About Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c... NAVB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT